FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to production of biologically active pharmaceutical and medical materials. Disclosed is a bioactive composite based on hydroxyapatite, in which titanium monoxide is dispersed. Material contains super-stoichiometric titanium monoxide TiO1,22 as titanium monoxide, with the following ratio of components, wt%: hydroxyapatite – 77–79, titanium monoxide TiO1,22 – 21–23.
EFFECT: proposed bioactive composite material has disinfective capacity along with high microhardness and can be used for reconstruction and replacement of bone tissue, prosthetics of fragments of locomotor system.
1 cl, 1 tbl, 2 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITE BIOMATERIAL BASED ON HYDROXYAPATITE AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2816008C1 |
BIORESORBABLE MATERIAL AND METHOD FOR PRODUCING THEREOF | 2017 |
|
RU2652429C1 |
BIOMEDICAL MATERIAL BASED ON HYDROXYAPATITE AND METHOD FOR ITS PRODUCTION | 2022 |
|
RU2782925C1 |
BIOACTIVE COMPOSING MATERIAL FOR REPLACEMENT OF BONE DEFECTS AND METHOD FOR PRODUCING THEREOF | 2018 |
|
RU2683255C1 |
BIOACTIVE COATING FOR BONE TISSUE RECOVERY | 2019 |
|
RU2717676C1 |
HYDROXYAPATITE-BASED COMPOSITE MATERIAL FOR BONE IMPLANTS AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2771382C1 |
BIOMATERIAL BASED ON HYDROXYAPATITE | 2020 |
|
RU2735032C1 |
BIOMATERIAL BASED ON HYDROXYAPATITE | 2020 |
|
RU2741208C1 |
METHOD FOR PRODUCING BIOMEDICAL MATERIAL | 2015 |
|
RU2599039C1 |
OSTEOPLASTIC MATERIAL FOR BONE DEFECT REPLACEMENT | 2024 |
|
RU2824989C1 |
Authors
Dates
2020-06-25—Published
2020-03-12—Filed